|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/24 | |
| A61K 39/395 | |||
| A61P 19/10 |
| (11) | Patento numeris | 2245062 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 09702831.0 |
| Europos patento paraiškos padavimo data | 2009-01-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2010-11-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-04-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2009/031126 |
| Data | 2009-01-15 |
| (87) | Numeris | WO 2009/091905 |
| Data | 2009-07-23 |
| (30) | Numeris | Data | Šalis |
| 21218 P | 2008-01-15 | US |
| (72) |
BEBBINGTON, Christopher R., US
YARRANTON, Geoffrey T., US
|
| (73) |
Kalobios Pharmaceuticals, Inc.,
260 East Grand Avenue, South San Francisco, CA 94080,
US
|
| (54) | METHODS OF TREATING BONE-LOSS DISORDERS USING A GM-CSF ANTAGONIST |
| METHODS OF TREATING BONE-LOSS DISORDERS USING A GM-CSF ANTAGONIST |